Detalhe da pesquisa
1.
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Biol Blood Marrow Transplant
; 23(10): 1631-1640, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533060
2.
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.
Hematol Oncol
; 36(5): 765-772, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129233
3.
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.
Hematol Oncol Stem Cell Ther
; 12(4): 194-203, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319058
4.
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.
Cancer Med
; 6(12): 2766-2774, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29076254
5.
Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
Bone Marrow Transplant
; 53(6): 780-783, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362504
6.
[Septic shock with purpura fulminans due to Capnocytophaga canimorsus]. / Shock séptico con purpura fulminans por Capnocytophaga canimorsus.
Enferm Infecc Microbiol Clin
; 22(5): 309-10, 2004 May.
Artigo
em Espanhol
| MEDLINE | ID: mdl-15207129